Compass Therapeutics Inc (CMPX)

Nov 22, 2024

Layoff Tracker: Sonata Therapeutics Laying Off 20 Employees, Changing Leadership - BioSpace

Nov 22, 2024

Nov 21, 2024

Down -23.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Compass Therapeutics, Inc. (CMPX) - Yahoo Canada Finance

Nov 21, 2024

Nov 18, 2024

FY2024 EPS Estimates for BCAX Cut by Cantor Fitzgerald - Defense World

Nov 18, 2024

Nov 18, 2024

Compass Therapeutics (NASDAQ:CMPX) Cut to Market Perform at Leerink Partners - Defense World

Nov 18, 2024

Nov 17, 2024

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Update - MarketBeat

Nov 17, 2024

Nov 16, 2024

What Makes Compass Therapeutics, Inc. (CMPX) a New Buy Stock - MSN

Nov 16, 2024

Nov 16, 2024

2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious - MSN

Nov 16, 2024

Nov 16, 2024

Leerink Partnrs Downgrades Compass Therapeutics (NASDAQ:CMPX) to Hold - MarketBeat

Nov 16, 2024

Nov 15, 2024

DelphX announces non-brokered unit private placement - MSN

Nov 15, 2024

Nov 15, 2024

U.S. STOCKS FuelCell Energy, consumer goods stocks, Rocket Companies - XM

Nov 15, 2024

Nov 15, 2024

Compass Therapeutics (NASDAQ:CMPX) Downgraded to "Market Perform" Rating by Leerink Partners - MarketBeat

Nov 15, 2024

Nov 15, 2024

Wedbush Expects Higher Earnings for Compass Therapeutics - MarketBeat

Nov 15, 2024

Nov 15, 2024

What is HC Wainwright's Forecast for CMPX FY2024 Earnings? - MarketBeat

Nov 15, 2024

Nov 14, 2024

Compass Therapeutics Inc (CMPX) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 14, 2024

Janus Henderson Group PLC's Strategic Reduction in Compass Thera - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment - Benzinga

Nov 14, 2024

Nov 14, 2024

What is HC Wainwright's Estimate for CMPX FY2028 Earnings? - MarketBeat

Nov 14, 2024

Nov 13, 2024

Compass Therapeutics Reports Q3 2024 Financials and Clinical Progress - TipRanks

Nov 13, 2024

Nov 13, 2024

Compass Therapeutics to Participate in Upcoming Investor Events - The Manila Times

Nov 13, 2024

Nov 13, 2024

Compass Therapeutics (CMPX) to Present at Stifel and Jefferies Healthcare Conferences | CMPX Stock News - StockTitan

Nov 13, 2024

Nov 13, 2024

PD-1 and PD-L1 Inhibitors Market Projected to Surge, Reaching USD XX Billion by 2031 As Revealed In New Report - WhaTech

Nov 13, 2024

Nov 12, 2024

Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

Compass Therapeutics Reports Key Trial Progress, $135M Cash Runway Through 2027 | CMPX Stock News - StockTitan

Nov 12, 2024

Nov 11, 2024

HC Wainwright Reaffirms "Buy" Rating for Compass Therapeutics (NASDAQ:CMPX) - MarketBeat

Nov 11, 2024

Nov 08, 2024

Compass Therapeutics Presents Novel Biomarker Data Related - GlobeNewswire

Nov 08, 2024

Nov 05, 2024

US Penny Stocks To Watch: 3 Picks With Market Caps Over $40M - Simply Wall St

Nov 05, 2024

Nov 04, 2024

Treatment Resistant Depression Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - Barchart

Nov 04, 2024

Nov 04, 2024

Treatment Resistant Depression Pipeline Therapeutics, - openPR

Nov 04, 2024

Oct 31, 2024

Compass delays anticipated psilocybin readout, cuts staff - Yahoo Finance

Oct 31, 2024

Oct 27, 2024

Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024 - MD Magazine

Oct 27, 2024

Oct 16, 2024

Treatment Resistant Depression Clinical Trials 2024: FDA - openPR

Oct 16, 2024

Oct 16, 2024

Biotech stock tumbles after unexplained 1,446% gain - MSN

Oct 16, 2024

Oct 15, 2024

Cholangiocarcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Oct 15, 2024

Oct 15, 2024

Can you now get a good deal on Compass Therapeutics Inc’s shares? - US Post News

Oct 15, 2024

Oct 15, 2024

Financial Snapshot: Analyzing Compass Therapeutics Inc (CMPX)’s Key Ratio Metrics - The Dwinnex

Oct 15, 2024

Oct 15, 2024

Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market - Investing News Network

Oct 15, 2024

Oct 14, 2024

CMPX’s 2023 Market Dance: Up 26.92% – Time to Invest? - The InvestChronicle

Oct 14, 2024

Oct 14, 2024

Renaissance Technologies LLC Decreases Position in Imperial Petroleum Inc. (NASDAQ:IMPP) - Defense World

Oct 14, 2024

Oct 14, 2024

JetBlue Airways (NASDAQ:JBLU) Raised to “Sell” at StockNews.com - Defense World

Oct 14, 2024

Oct 08, 2024

Cholangiocarcinoma Clinical Trials 2024: EMA, PDMA, FDA - openPR

Oct 08, 2024

Oct 08, 2024

Silicon Laboratories Inc. (NASDAQ:SLAB) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Oct 08, 2024

Oct 04, 2024

Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - ForexTV.com

Oct 04, 2024

Oct 04, 2024

Compass Therapeutics Announces Upcoming Poster Presentation - GlobeNewswire

Oct 04, 2024

Oct 03, 2024

Compass Therapeutics Inc (CMPX)’s stock price range in the last year - US Post News

Oct 03, 2024

Oct 02, 2024

American Century Companies Inc. Cuts Stake in Compass Minerals International, Inc. (NYSE:CMP) - Defense World

Oct 02, 2024

Sep 30, 2024

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.7% in September - MarketBeat

Sep 30, 2024

Sep 30, 2024

Rhumbline Advisers Takes Position in LINKBANCORP, Inc. (NASDAQ:LNKB) - Defense World

Sep 30, 2024

Sep 30, 2024

Rhumbline Advisers Trims Holdings in Pembina Pipeline Co. (NYSE:PBA) - Defense World

Sep 30, 2024

Sep 29, 2024

Analyzing Neurocrine Biosciences (NASDAQ:NBIX) and Compass Therapeutics (NASDAQ:CMPX) - Defense World

Sep 29, 2024

Sep 27, 2024

NSK (OTCMKTS:NPSKY) Stock Price Passes Above 50-Day Moving Average of $10.02 - Defense World

Sep 27, 2024